Ymmunobio is a preclinical stage oncology biotech company focused on the development of innovative treatments for cancer patients through new classes of antibodies. Those treatments present a large market potential and broad applicability in solid tumors. Ymmunobio is making extensive progress in developing antibodies that have unique features of fighting cancers.
View Top Employees from YmmunobioWebsite | https://www.ymmuno.bio |
Employees | 6 (1 on RocketReach) |
Founded | 2021 |
Industry | Biotechnology Research |
Looking for a particular Ymmunobio employee's phone or email?
1 people are employed at Ymmunobio.